Exelixis | Vermögenswerte



Assets Veränderung Datum
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
Agios Pharmaceuticals USD 1.47B 84.28M 2025-06
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 112.42B 6.17B 2025-06
Bayer EUR 109.18B 1.67B 2025-03
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Cytokinetics USD 1.26B 137.62M 2025-03
Eisai JPY 1.39T 46.32B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Exelixis USD 2.68B 159.17M 2025-07
Genmab DKK 6.59B 39.22B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.82B 71.99M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Moderna USD 12.01B 694M 2025-06
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 208.03B 5.37B 2025-03
Sanofi 132.8B 3.04B 2024-12
Takeda JPY 14T 243.81B 2025-06
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Xencor USD 904.69M 47.26M 2025-03


Exelixis Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.